NYSE · Medical - Devices

ITGR (ITGR) Stock

$100.38 +0.99% NYSE: ITGR Healthcare

Valuation

MetricValue
Price$100.38
Market Cap$3.41B
P/E Ratio31.13
P/B Ratio1.75
P/S Ratio1.65
EPS (TTM)$2.89
52-Week High$123.78
52-Week Low$62.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE5.90%
ROA3.02%
ROCE11.96%
Gross Margin11.32%
Operating Margin11.32%
Net Margin7.67%
Debt/Equity0.81
Current Ratio3.32

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.2B$1.3B$1.6B$1.7B$1.8B
Operating Profit$136.0M$113.0M$163.0M$208.0M$209.0M
Net Profit$97.0M$66.0M$91.0M$120.0M$103.0M
EPS$2.80$1.96$2.69$3.40$2.89
Op Margin11.1%8.5%10.5%12.1%11.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$2.6B$2.8B$2.9B$3.1B$3.4B
Total Liabilities$1.2B$1.4B$1.4B$1.5B$1.7B
Cash$18.0M$24.0M$24.0M$47.0M$17.0M
Borrowings$906.0M$1.0B$1.1B$1.1B$1.4B

Latest News

Truist Securities Adjusts Price Target on Integer Holdings to $110 From $97, Maintains Buy Rating MT Newswires · Jul 16, 2026 Reflecting On Medical Devices & Supplies - Specialty Stocks’ Q1 Earnings: Integer Holdings (NYSE:ITGR) StockStory · Jul 14, 2026 3 Small-Cap Stocks We Think Twice About StockStory · Jul 13, 2026 Integer Announces Conference Call to Discuss Second Quarter 2026 Results GlobeNewswire · Jul 2, 2026 3 Value Stocks We Find Risky StockStory · Jul 1, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$157.0M$116.0M$180.0M$205.0M$196.0M
Investing Cash Flow$-324.0M$-275.0M$-283.0M$-301.0M$-362.0M
Financing Cash Flow$-14.0M$-2.0M$-46.0M$-4.0M$-137.0M
Net Cash Flow$-31.0M$6.0M$-1.0M$23.0M$-29.0M
Free Cash Flow$103.0M$42.0M$60.0M$100.0M$105.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA13.25
FCF Yield4.71%
Quick Ratio2.38
Interest Coverage4.98
Return 1Y-15.85%
Return 3Y11.80%
Return 5Y4.65%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADUS $116.46 +2.46% 17.77 $2.17B 0.00%
AORT $27.12 +2.07% 108.24 $1.32B 0.00%
CON $30.76 -1.16% 19.32 $3.94B 0.99%
HAE $83.60 -2.08% 37.62 $3.80B 0.00%
INSP $50.93 +3.54% 8.73 $1.47B 0.00%

About ITGR

ITGR stock trades at $100.38 with a market capitalization of $3.41B. The stock is valued at a price-to-earnings (P/E) ratio of 31.13, price-to-book of 1.75, price-to-sales of 1.65. Over the past 52 weeks the stock has ranged between $62.00 and $123.78, and currently trades 18.9% below its 52-week high.

On profitability, ITGR generates a return on equity (ROE) of 5.90%, return on capital employed of 11.96%, an operating margin of 11.32%, a net profit margin of 7.67%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides